俊宏固肾生发丸品牌怎么样 申请店铺

我要投票 俊宏固肾生发丸在生发行业中的票数:767 更新时间:2026-01-11
俊宏固肾生发丸是哪个国家的品牌?「俊宏固肾生发丸」是 吉林省俊宏药业有限公司 旗下著名品牌。该品牌发源于吉林省通化市,由创始人张士俊在2001-09-04期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力俊宏固肾生发丸品牌出海!将品牌入驻外推网,定制俊宏固肾生发丸品牌推广信息,可以显著提高俊宏固肾生发丸产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

俊宏固肾生发丸怎么样

辉南县位于中药材资源丰富的长白山麓松花江畔,地处吉林省东南部,隶属通化市管辖,东南与靖宇县毗邻,西距梅河口市45公里,南与柳河县接壤,东与桦甸市相边,北与磐石市隔江相望,县城朝阳镇位于辉南县西北角部,素有“参鹿之乡,医药名城”之美誉。俊宏药业有限公司就位于县城东北部,辉南经济开发区内。

俊宏药业有限公司成立于1990年,注册资金5000万元,2001年由长春搬迁到辉南,并按GMP标准实施改造工程。于2003年初整体通过了国家药品GMP认证并投入正式生产。公司类型为民营有限责任公司,资产总额5.5亿元。公司占地面积21万平方米,建筑面积5.8万平方米,现有员210人,各类专业技术人员70余人,其中具有高级职称9人,职业药师7人。公司现有前处理提取车间、固体制剂车间、保健用品车间、中心化验室等四个车间和七个职能管理科室。有胶囊剂、片剂、颗粒剂、散剂、水丸、蜜丸、浓缩丸、水蜜丸、糊丸、中药饮片和贴膏剂、软膏剂、液体制剂等13个剂型,共有87个国药准字号中成药生产品种和33个吉卫健用字号保健用品生产品种,其中获国家中药保护品种1个。公司拥有完备的生产设备和精湛的工艺技术,是一个已通过新修订的国家药品GMP认证、以固体制剂为主体的现代化中成药制药和保健用品生产企业。

公司自成立以来一贯奉行以市场为导向,以产品为载体,以质量为生命的生产经营宗旨。按照现代化企业制度的要求,规范管理机制,强化营销策略,坚持内抓管理,外拓市场,以质量求生存,靠信誉求发展的经营理念。凭借高质量的产品和良好的商业信誉,已在全国大部分省市建立了自己的销售网络,产品销售量逐年增加,各项经济指标逐年增长。

公司把建设“规模强大,实力雄厚,效益显著”的科技创新型企业作为发展战略,已与省中医药研究院、吉大药学院等科研机构、大专院校建立了合作关系,成功开发了一系列新药特药,其中研制开发的保健用品产品种已获批号33个,目前已正式投产上市,公司将不断研制开发高科技新产品,以使企业实力不断增强,朝更高、更强的目标迈进,为医药行业的繁荣发展而做出贡献。


Huinan County is located on the Bank of Songhua River at the foot of Changbai Mountain, which is rich in traditional Chinese medicine resources. It is under the jurisdiction of Tonghua city. It is adjacent to Jingyu County in the southeast, 45km away from Meihekou city in the west, Liuhe County in the south, Huadian City in the East and Panshi City in the north. Chaoyang Town, located in the northwest corner of Huinan County, is known as the "hometown of shenlu and famous medical city". Junhong Pharmaceutical Co., Ltd. is located in Huinan Economic Development Zone in the north of the east of the county. Junhong Pharmaceutical Co., Ltd. was founded in 1990 with a registered capital of 50 million yuan. It was moved from Changchun to Huinan in 2001, and the transformation project was implemented according to GMP standards. At the beginning of 2003, it passed the national GMP certification and put into formal production. The company is a private limited liability company with total assets of RMB 550 million. The company covers an area of 210000 square meters, with a building area of 58000 square meters. There are 210 employees and more than 70 professional and technical personnel, including 9 with senior titles and 7 professional pharmacists. The company has four workshops and seven functional management departments, including pretreatment and extraction workshop, solid preparation workshop, health care supplies workshop, and central laboratory. There are 13 dosage forms including capsule, tablet, granule, powder, water pill, honey pill, concentrated pill, water honey pill, paste pill, Chinese herbal pieces and pastes, ointment, liquid preparation, etc. there are 87 production varieties of Chinese patent medicine under the state drug registration number and 33 production varieties of health care products under the Ji Wei Jian use number, of which one is under the state protection of traditional Chinese medicine. The company has complete production equipment and exquisite technology. It is a modern Chinese patent medicine and health care products manufacturer that has passed the newly revised national GMP certification and takes solid preparations as the main body. Since its establishment, the company has always adhered to the production and operation tenet of market-oriented, product-oriented and quality-oriented. According to the requirements of modern enterprise system, standardize the management mechanism, strengthen the marketing strategy, adhere to the business philosophy of internal management, external market expansion, survival by quality and development by reputation. With high-quality products and good business reputation, we have established our own sales network in most provinces and cities of the country. The sales volume of products increases year by year, and the economic indicators increase year by year. The company takes the construction of a scientific and technological innovation enterprise with "strong scale, strong strength and remarkable benefits" as its development strategy. It has established cooperative relations with scientific research institutions and colleges and universities such as Provincial Institute of traditional Chinese medicine, Jida College of medicine, etc., and has successfully developed a series of new drugs and specialty drugs, including 33 batches of health care products, which have been officially put into production and listed. The company will We will continue to develop new high-tech products, so as to enhance the strength of the enterprise, move towards a higher and stronger goal, and contribute to the prosperity and development of the pharmaceutical industry.

本文链接: https://brand.waitui.com/e70e8902c.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

金价银价大幅波动原因,多家机构预计贵金属今年仍有上涨空间

华尔街投行高盛指出,预计相较黄金交易来说,白银交易将持续面临高波动性和不确定性。综合多家金融机构的分析来看,本周有两个因素加剧了贵金属价格的下行压力。一是彭博大宗商品指数本周启动年度再平衡调整,贵金属权重被大幅下调,分析人士称,预计这次再平衡调整会触发指数追踪型资金被动减仓,使得黄金和白银面对获利了结压力。二是芝商所集团从周五盘后起,再次上调黄金、白银、铂金和钯金等贵金属期货履约保证金,这是最近一个月以来,芝商所集团第三次上调贵金属期货保证金。(央视财经)

43分钟前

2025年上合示范区中欧班列开行量和货运量再创新高

青岛海关消息,2025年,青岛海关监管上合示范区到发中欧班列1225列、进出口货物84万吨,班列开行量和货运量均增长超两成,创历史同期新高。上合示范区启动建设以来,已累计到发中欧班列5491列,发运集装箱45万标箱,运送进出口货物380万吨。(央视新闻)

43分钟前

印度拟要求智能手机制造商向政府共享源代码 遭苹果三星等反对

印度拟出台多项安全措施,要求智能手机制造商向政府共享源代码并对软件进行多项修改,此举引发苹果、三星等科技巨头的私下反对。据四名知情人士透露,以及对政府和行业机密文件的核查结果显示,上述措施包含 83 项安全标准,其中还要求企业在推送重大软件更新时向政府报备。这些科技企业反驳称,这套安全标准在全球范围内尚无先例可循,且存在泄露企业专有信息的风险。(财联社)

43分钟前

仙坛股份:2025年12月鸡肉产品销售收入增长9.41%

36氪获悉,仙坛股份公告,公司2025年12月实现鸡肉产品销售收入5.29亿元,销售数量5.51万吨,同比变动分别为9.41%和6.76%。

43分钟前

达尔环球公司与特朗普集团将启动价值100亿美元的新沙特房地产项目

达尔环球CEO表示,达尔环球公司与特朗普集团将启动价值100亿美元的新沙特房地产项目。(财联社)

43分钟前

本页详细列出关于俊宏固肾生发丸的品牌信息,含品牌所属公司介绍,俊宏固肾生发丸所处行业的品牌地位及优势。
咨询